U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (JHL1188)Cat. No. WA1624Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (JHL1188)Cat. No. WA1624
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (IGN001)Cat. No. WA1623
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (HuMax-Her2)Cat. No. WA1622
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (HuA21)Cat. No. WA1621
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (HMBD-001)Cat. No. WA1620
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (H2Mab-139)Cat. No. WA1619
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (GNR-027)Cat. No. WA1618
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (GB251)Cat. No. WA1617
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (FS102)Cat. No. WA1616
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (DXL702)Cat. No. WA1615
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (DP303C)Cat. No. WA1614
U-Blot® Research Grade Anti-Human CD340/ERBB2/HER2/NEU (DHES0815A)Cat. No. WA1613